[ad_1]
The European Medicines Agency (EMA) bases its regulatory decisions on different types of data. These include ‘big data’ sources like real-world evidence obtained from electronic health records and patient registries. EMA uses rigorous and transparent analytics, such as advanced artificial intelligence-driven methods, to generate insights and evidence that support decisions on the safety, efficacy, and quality of medicines.
[ad_2]
Source link